Brief: Boehringer Ingelheim, Cue Biopharma Partner To Develop Autoimmune And Inflammatory Disease Treatments
14/04/2025 22:34
April 14 (Reuters) - Cue Biopharma Inc CUE.O: BOEHRINGER INGELHEIM AND CUE BIOPHARMA PARTNER TO DEVELOP TREATMENT FOR AUTOIMMUNE AND INFLAMMATORY DISEASES CUE BIOPHARMA INC: UNDER COLLABORATION, CO TO RECEIVE UP-FRONT PAYMENT OF $12 MILLION AS WELL AS RESEARCH SUPPORT PAYMENTS CUE BIOPHARMA INC: CO IS ALSO ELIGIBLE TO EARN UP TO ABOUT $345 MILLION IN MILESTONE-BASED PAYMENTS Source text: ID:nGNX8hQfzZ Further company coverage: CUE.O ((Reuters.Briefs@thomsonreuters.com;))